Company news: Haymarket Medical, Johnson & Johnson

Share this article:
Company news: Haymarket Medical, Johnson & Johnson
Company news: Haymarket Medical, Johnson & Johnson

Hitting the 1,000-download mark in less than a week, Haymarket Medical said its new myCME app has been an iTunes top 10 US medical app ever since. The May 10 launch was a universal app for iPhone/iPad and iPod users. An Android version will be released later this month. MM&M is a Haymarket title. 


Advanced prostate cancer drug Zytiga could help men who are in the earlier stages of the disease, reported the New York Times. The report was based on small, six-month clinical trial in which the Johnson & Johnson drug was added to standard therapy. The Times reported that the combination cleared or nearly eliminated tumors in about a third of the men whose cancer was still limited to the prostate gland. Full results will be reported at the American Society of Oncology's June conference in Chicago.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Illumina inks deal with J&J, AstraZeneca, Sanofi

The goal is to develop companion diagnostics to match patients with cancer treatments.

Abbott deal highlights inversion inaction

Political furor over the recent spate of tax inversions is having little influence on how the government chooses its partners.

Allergan reported to seek out Salix deal

The Wall Street Journal says the deal would add "another layer of intrigue" to the Allergan-Valeant hostilities.